MOBILion Systems Establishes Proteomics Advisory Board
MOBILion Systems Establishes Proteomics Advisory Board
Today, MOBILion Systems, Inc., a recognized pioneer in separation science innovation, has announced the formation of a Proteomics Advisory Board. This new board signifies the company’s ongoing commitment to revolutionizing the field of proteomics through state-of-the-art technology and collaborative expertise.
Enhancing the Field of Proteomics
The Proteomics Advisory Board will play a crucial role by providing strategic insights as MOBILion moves forward with its next-generation methods. This approach is set to transform the landscape of complex sample analysis, with initial applications focusing on proteomics and promising countless possibilities for future advancements.
Daniel DeBord, Ph.D., Chief Technology Officer at MOBILion Systems, expressed excitement about collaborating with leading experts in the proteomics field. "We are honored to work alongside such visionary leaders whose innovative contributions have significantly impacted proteomics. Our goal is to establish new benchmarks in speed and sensitivity for complex sample analysis, and the expertise of this board is vital in developing solutions that directly tackle the challenges researchers encounter in proteomics research," he stated, highlighting the board's importance to the company’s mission.
Meet the Advisory Board
The newly formed advisory board includes seven distinguished scientists and authorities in proteomics, with plans for further expansion based on the evolving needs of applications and workflows:
Key Board Members
- Steven Carr, Ph.D. – Senior Director of Proteomics at the Broad Institute of MIT and Harvard, celebrated for his groundbreaking work in proteomic methodologies.
- Ashok Dongre, Ph.D. – Senior Director and Head of Proteomics at Bristol Myers Squibb, possessing over 25 years of pharmaceutical research leadership.
- Alexey Nesvizhskii, Ph.D. – Godfrey Dorr Stobbe Professor of Bioinformatics at the University of Michigan, known for his influential contributions in mass spectrometry and bioinformatics.
- Ben Orsburn, Ph.D. – Established researcher in mass spectrometry from Johns Hopkins University School of Medicine, with vast experience in developing proteomic technologies.
- Birgit Schilling, Ph.D. – Professor at the Buck Institute for Research on Aging, specializing in data-driven proteomics studies.
- Nikolai Slavov, Ph.D. – Professor in the Department of Bioengineering at Northeastern University, recognized for his innovations in single-cell proteomics.
- John R. Yates III, Ph.D. – Ernest W. Hahn Professor at The Scripps Research Institute, a leading figure in the development of proteomics technologies.
Groundbreaking Technological Advancements
Recently, MOBILion unveiled a revolutionary technology that has the potential to change the landscape of the mass spectrometry industry. This advancement aims to deliver superior speed, sensitivity, specificity, and quantitative accuracy for workflows in proteomics, lipidomics, and metabolomics. A recent white paper elaborated on this innovative method, which enables fragmentation analysis at remarkable speeds using the company’s proprietary SLIM-based high-resolution ion mobility technology.
The Parallel Accumulation with Mobility Aligned Fragmentation (PAMAF) technique developed by MOBILion eliminates the traditional quadrupole filter. This pivotal change enhances throughput and efficiency in ion utilization, allowing for improved detection of low-abundance signals and providing exceptional precision in identifying complex biomolecules. Initially targeting proteomics, this groundbreaking method is designed for speed, specificity, and sensitivity in analyses, effectively pushing the boundaries of what is feasible within the field.
About MOBILion Systems, Inc.
MOBILion Systems is at the forefront of advancing separation science, offering tools that enable deeper, more accurate, and efficient analysis of complex molecules and samples. The company is driving progress across various sectors, from biopharma discovery to food safety and environmental testing, with a focus on providing greater resolution than traditional approaches. Their technology integrates effectively with mass spectrometry, facilitating complex analytical workflows. With their innovative advancements, MOBILion is reshaping the standards of what is achievable, all while just beginning to unveil its potential.
Frequently Asked Questions
What is the purpose of the Proteomics Advisory Board?
The Proteomics Advisory Board provides strategic guidance to help MOBILion Systems advance its next-generation methods in proteomics, ensuring innovative solutions are developed to address current challenges.
Who are the members of the Proteomics Advisory Board?
The board comprises esteemed scientists, including Steven Carr, Ph.D., Ashok Dongre, Ph.D., and others, each bringing extensive experience and expertise from prominent institutions and companies in bioinformatics and proteomics.
How does the PAMAF technology work?
PAMAF technology utilizes a unique approach that removes traditional quadrupole filters, greatly increasing throughput and efficiency in ion utilization, which enhances detection capabilities for complex biomolecules.
What industries will benefit from MOBILion's advancements?
MOBILion Systems' innovations are set to benefit sectors including biopharma, environmental testing, and food safety, promoting precise and efficient analytical methods.
How can I learn more about MOBILion Systems?
For additional information about MOBILion Systems and their technological innovations, you can visit their official website at www.mobilionsystems.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.